Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.

[1]  Y. Yamagata,et al.  Preparation of a copoly (dl-lactic/glycolic acid)-zinc oxide complex and its utilization to microcapsules containing recombinant human growth hormone. , 2003, International journal of pharmaceutics.

[2]  John Samuel,et al.  Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro , 2002, Pharmaceutical Research.

[3]  Y. Kawashima,et al.  Prolonged Anti-Inflammatory Action of DL-Lactide/Glycolide Copolymer Nanospheres Containing Betamethasone Sodium Phosphate for an Intra-Articular Delivery System in Antigen-Induced Arthritic Rabbit , 2002, Pharmaceutical Research.

[4]  X. Xuan,et al.  Comparison of the accessory activity of murine peritoneal cavity macrophage derived dendritic cells and peritoneal cavity macrophages in a mixed lymphocyte reaction. , 2001, The Journal of veterinary medical science.

[5]  J L Cleland,et al.  Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. , 2001, Journal of pharmaceutical sciences.

[6]  J L Cleland,et al.  Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[7]  E. Mathiowitz,et al.  Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Yoshiaki,et al.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. , 1999, International journal of pharmaceutics.

[9]  Y. Kawashima,et al.  Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  M A Tracy,et al.  Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. , 1999, Biomaterials.

[11]  H. Okada,et al.  One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. , 1997, Advanced drug delivery reviews.

[12]  H Bernstein,et al.  Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis. , 1997, Journal of biomedical materials research.

[13]  Yoshiaki,et al.  Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .

[14]  Y. Mizushima,et al.  Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. , 1982, Annals of the rheumatic diseases.

[15]  Y. Mizushima,et al.  Use of a lipid emulsion as a novel carrier for corticosteroids , 1982, The Journal of pharmacy and pharmacology.

[16]  H. Okada,et al.  Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers , 2004, Pharmaceutical Research.

[17]  Steven P Schwendeman,et al.  Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.

[18]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[19]  Toguchi Hajime,et al.  Drug delivery using biodegradable microspheres , 1994 .

[20]  S. Davis,et al.  Nanoparticles in drug delivery. , 1987, Critical reviews in therapeutic drug carrier systems.

[21]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.